Baseline Lipophilicity Relationships in Human Cytochromes P450 Associated with Drug Metabolism

References

• Anzenbacher P., Anzenbacherova E. Cytochromes P450 and metabolism of xenobiotics. Cell. Mol. Life Sci. 2001; 58: 737–747
   PubMed Web of Science ®Google Scholar
• Bauer C., Osman A. M., Cercignani G., Gialluca N., Paolini M. A unified theory of enzyme kinetics based upon the systematic analysis of the variations of kcat, Km, and kcat/Km and the relevant ΔGo values—possible implications in chemotherapy and biotechnology. Biochem. Pharmacol. 2001; 61: 1049–1055
   PubMed Web of Science ®Google Scholar
• Creighton T.E. Proteins: Structure and Molecular Properties. 1993
   Google Scholar
• Ekins S., Wrighton S. A. The role of CYP2B6 in human xenobiotic metabolism. Drug Metab. Rev. 1999; 31: 719–754
   PubMed Web of Science ®Google Scholar
• Ekins S., Bravi G., Wikel J. H., Wrighton S. A. Three-dimensional quantitative structure-activity relationship analysis of cytochrome P4503A4 substrates. J. Pharmacol. Exp. Ther. 1999; 291: 424–433
   PubMed Web of Science ®Google Scholar
• Ferrari S., Leeman T., Dayer P. The role of lipophilicity in the inhibition of polymorphic cytochrome P450IID6 oxidation by beta-blocking agents in vitro. Life Sci. 1991; 48: 2259–2265
   PubMed Web of Science ®Google Scholar
• Gao H., Hansch C. QSARs of P450 oxidation: on the value of comparing kcat and Km with kcat/Km. Drug Metab. Rev. 1996; 28: 513–526
   PubMed Web of Science ®Google Scholar
• Hansch C., Leo A. Substituent Constants for Correlation Analysis in Chemistry and Biology. Wiley, New York 1979
   Google Scholar
• Hansch C., Zhang L. Quantitative structure-activity relationships of cytochrome P450. Drug Metab. Rev. 1993; 25: 1–48
   PubMed Web of Science ®Google Scholar
• Hosea N. A., Miller G. P., Guengerich F. P. Elucidation of distinct ligand binding sites for cytochrome P4503A4. Biochemistry 2000; 39: 5929–5939
   PubMed Web of Science ®Google Scholar
• Kenworthy K. E., Bloomer J. C., Clarke S. E., Houston J. B. CYP3A4 drug interactions: correlations of 10 in vitro probe substrates. Br. J. Clin. Pharmacol. 1999; 48: 716–727
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V. Cytochromes P450: Structure, Function and Mechanism. Taylor&Francis, London 1996
   Google Scholar
• Lewis D. F. V. On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics. Biochem. Pharmacol. 2000a; 60: 293–306
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V. Structural characteristics of human P450s involved in drug metabolism: QSARs and lipophilicity profiles. Toxicology 2000b; 144: 197–203
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V. Modelling human cytochromes P450 for evaluating drug metabolism: an update. Drug Metab. Drug Interactions 2000c; 16: 307–324
   PubMedGoogle Scholar
• Lewis D. F. V. Guide to Cytochromes P450 Structure and Function. Taylor&Francis, London 2001
   Google Scholar
• Lewis D. F. V. Molecular modeling of human cytochrome P450-substrate interactions. Drug Metab. Rev. 2002a; 34: 55–67
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V. Homology modelling of human CYP2 family enzymes based on the CYP2C5 structure. Xenobiotica 2002b; 32: 305–323
   PubMedGoogle Scholar
• Lewis D. F. V., Broughton H. B. Molecular binding interactions: their estimation and rationalization in QSARs in terms of theoretically derived parameters. Sci. World 2002; 2: 1776–1802
   Google Scholar
• Lewis D. F. V., Dickins M. Factors influencing rates and clearance in P450-mediated reactions: QSARs for substrates of the xenobiotic-metabolizing hepatic microsomal P450s. Toxicology 2002a; 170: 45–53
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Dickins M. Substrate SARs in human P450s. Drug Discov. Today 2002b, in press
   Web of Science ®Google Scholar
• Lewis D. F. V., Eddershaw P. J., Dickins M., Tarbit M. H., Goldfarb P. S. Structural determinants of P450 substrate specificity, binding affinity and catalytic rate. Chem. Biol. Interact. 1998; 115: 175–199
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Modi S., Dickins M. Quantitative structure-activity relationships (QSARs) within substrates of human cytochromes P450 involved in drug metabolism. Drug Metab. Drug Interact. 2001; 18: 221–241
   PubMedGoogle Scholar
• Lewis D. F. V., Modi S., Dickins M. Structure-activity relationships for human cytochrome P450 substrates and inhibitors. Drug Metab. Rev. 2002; 34: 69–82
   PubMed Web of Science ®Google Scholar
• Lipnick R. L., Johnson D. E., Gilford J. H., Bickings C. K., Newsome L. D. Comparison of fish toxicity screening data for 55 alcohols with the quantitative structure-activity relationship predictions of minimum toxicity for nonreactive nonelectrolyte organic compounds. Environ. Toxicol. Chem. 1985; 4: 281–296
   Web of Science ®Google Scholar
• Mancy A., Broto P., Dijols S., Dansette P. M., Mansuy D. The substrate binding site of human liver cytochrome P4502C9: an approach using tienilic acid derivatives and molecular modelling. Biochemistry 1995; 34: 10365–10375
   PubMed Web of Science ®Google Scholar
• Miyazawa M., Shindo M., Shimada T. Roles of cytochrome P450 3A enzymes in the 2-hydroxylation of 1,4-cineole, a monoterpene cyclic ether, by rat and human liver microsomes. Xenobiotica 2001; 31: 713–723
   PubMed Web of Science ®Google Scholar
• Ortiz de Montellano P. R. Cytochrome P450. 2nd ed., Plenum, New York 1995
   Google Scholar
• Pelkonen O., Maenpaa J., Taavitsainen P., Rautio A., Raunio H. Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica 1998; 28: 1203–1253
   PubMed Web of Science ®Google Scholar
• Rendic S. Summary of information on human CYP enzymes: human CYP metabolism data. Drug Metab. Rev. 2002; 34: 83–448
   PubMed Web of Science ®Google Scholar
• Rendic S., DiCarlo F. J. Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers and inhibitors. Drug Metab. Rev. 1997; 29: 413–580
   PubMed Web of Science ®Google Scholar
• Sangster J. Octanol–water partition coefficients of simple organic compounds. J. Phys. Chem. Ref. Data 1989; 18: 1111–1229
   Web of Science ®Google Scholar
• Smith D. A., Jones B. C. Speculations on the substrate structure-activity relationship (SSAR) of cytochrome P450 enzymes. Biochem. Pharmacol. 1992; 44: 2089–2098
   PubMed Web of Science ®Google Scholar
• Suzuki T., Kudo Y. Automatic log P estimation based on combined additive modeling methods. J. Comput.-Aided Mol. Des. 1990; 4: 155–198
   PubMed Web of Science ®Google Scholar
• Ueng Y. -F., Kuwabara T., Chun Y. -J., Guengerich F. P. Cooperativity in oxidations catalyzed by cytochrome P4503A4. Biochemistry 1997; 36: 370–381
   PubMed Web of Science ®Google Scholar